Skip to main content
. 2000 Jan;119(1):231–239. doi: 10.1046/j.1365-2249.2000.01099.x

Fig. 3.

Fig. 3

Representation of the influence of different pretreatment regimens in SCID and NOD-SCID mice on the survival and spreading of transplanted Hu-PBL, on human immunoglobulin production, on the life span of the transplanted animals, on the severity of graft-versus-host disease (GVHD) and on the necessity of a booster dose for antigen-specific immunoglobulin production.